Global Report Predicts More Than 50% Market Growth in Monoclonal Antibody Biosimilars by 2024

The “Biosimilar Monoclonal Antibodies Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report indicates that the global biosimilar monoclonal antibodies market will grow with a compound annual growth rate of 55.2% between 2018 and 2024.

The report on the biosimilar monoclonal antibodies market presents drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global biosimilar monoclonal antibodies market over the period of 2016 to 2024 in leading geographic areas, including North America, Europe, and Asia-Pacific.

According to the report, drivers of this market growth include an increasing demand for more cost-effective biosimilar drugs and the prevalence of chronic diseases among an aging population. However, barriers to this growth include unfavorable government regulations in developed countries and the high costs associated with the manufacturing process. Growing collaboration among local players represents an opportunity in this market.

The report’s methodology includes extensive interviews and analyses of the opinions provided by the primary respondents, including key opinion leaders; internal and external subject matter experts; and professionals and participants from LinkedIn, Hoovers, Factiva, and various blogs. These respondents included executives, brand managers, and regional managers within the industry. Secondary research involved extensive analysis of both public and paid sources, which was cross-validated and fact-checked. Each research study is based on more than 500 hours of secondary research.

The report can be purchased at